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Tumors are composite of many different cellular and non‐cellular constituents that
surround the malignant cancer cells harboring activating mutations in oncogenes or loss of
tumor suppressors that drive tumor growth. A variety of infiltrating immune cells, cancer‐
associated fibroblasts, and angiogenic endothelial cells play expanding and critical
functions in sustaining cell proliferation, evading growth suppressors, promoting








Ref. J.W. Pollard. Nat Revs Cancer, 4, 71‐78 (2004)
Ref. T.L. Rogers and I. Holen. J Translational Med, 9:177 (2011)
Tumor‐associated macrophages (TAMs), which
are predominantly M2 polarized, affect virtually
all aspects of tumor growth and progression,
including stem cells, metabolism, angiogenesis,
invasion, metastasis, and therapeutic resistance.
Communication between tumor cells and
macrophages is critical for tumor malignancy.
Ref. S.K. Biswas & A. Montovani, Nat Immunol., 11: 889‐896 (2010). 
TAM Repolarization from M2 to M1 
 Reprogramming TAMs from a predominant M2 to M1 phenotype would
provide an opportunity for anti‐tumor response and potentially improve cancer
immunotherapy.
 Several microRNA’s (e.g., miR‐155 and miR‐125b) have shown to change











 Hyaluronic acid (HA) is a natural,
biocompatible, and biodegradable
polymer
 Long history of safe use in clinical
applications (e.g., for visco‐
supplementation therapy in
arthritis)
 Intrinsic targeting to CD44
receptors over‐expressed on tumor
cells (e.g., cancer stem cells) and
macrophages
 Modular HA nanoparticle platform
synthesized using different
functional substitutions (EDC
coupling or “click” chemical
cojugation)
 Combinatorial library of formed
nanoparticles by self‐assembly of
the constituents at specific weight























Human pancreatic cancer cells (Panc‐1) transfected with
plasmid DNA expressing miR‐155 and miR‐125b and the
levels of expression in cells relative to control were measured













(A) Quantitative qRT‐PCR analysis of expression of wt‐p53 in cells (p53/cells) and in exosomes (p53/exo) when
transfected with wt‐p53 expressing plasmid DNA alone or in combination with miRNA‐125b expressing plasmid DNA
in cells (combi/cells) and in exosomes (combi/exo) after 18 hours of incubation. (B) Quantitative qRT‐PCR analysis of
expression of miR‐125b expression in cells (miR‐125b/cells) and in exosomes (miR‐125b /exo) when transfected with
miRNA‐125b expressing plasmid DNA alone or in combination with wt‐p53 expressing plasmid DNA in cells
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 There is a significant need to facilitate clinical translation of advances in
molecular medicine into effective disease diagnosis and therapeutic
strategies.
 Nanotechnology has an important role to play in disease diagnosis,
imaging, and therapy and potentially may advance personalized medicine.
 In cancer, we are interested in reprogramming with exosome‐mediated
tumor microenvironment with genetic therapies using combinatorial‐
designed hyaluronic acid‐based nanoparticles platform.
 For anti‐inflammatory therapy, we are evaluating macrophage
repolarization approaches and have evaluated IL‐10 and microRNA‐223
delivery and transfection using CD44 targeting hyaluronic acid
nanoparticles.
 For each example, our focus is on solving important medical problems
with innovative solutions that use inexpensive and safe materials, as well
as, scalable fabrication methods so that these promising experimental
technologies are realized in the clinic in the near future.
